scholarly article | Q13442814 |
P356 | DOI | 10.1002/CNCR.33150 |
P698 | PubMed publication ID | 32926435 |
P50 | author | Jane Yc Hui | Q84010263 |
Schelomo Marmor | Q87769247 | ||
Ariella M Altman | Q89122072 | ||
Colleen F Longacre | Q89851631 | ||
Todd M Tuttle | Q91729081 | ||
P2093 | author name string | Eric H Jensen | |
P2860 | cites work | The ASA's statement on p-values: context, process, and purpose | Q24492532 |
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer | Q28297827 | ||
Comparison of SEER Treatment Data With Medicare Claims | Q30779910 | ||
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer | Q33996115 | ||
Guideline-concordant cancer care and survival among American Indian/Alaskan Native patients | Q34449821 | ||
Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives | Q34701416 | ||
Breast and cervical cancer screening patterns among American Indian women at IHS clinics in Montana and Wyoming | Q35258149 | ||
Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status | Q36249087 | ||
The experience of treatment barriers and their influence on quality of life in American Indian/Alaska Native breast cancer survivors | Q38558977 | ||
Access to ambulatory care for American Indians and Alaska Natives; the relative importance of personal and community resources | Q39388338 | ||
Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast. | Q40146584 | ||
21-Gene recurrence scores: racial differences in testing, scores, treatment, and outcome | Q44305971 | ||
Disparities in Prostate, Lung, Breast, and Colorectal Cancer Survival and Comorbidity Status among Urban American Indians and Alaskan Natives. | Q46001825 | ||
Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results. | Q48225891 | ||
Mortality Among American Indians and Alaska Natives | Q50110671 | ||
Breast cancer incidence among American Indian and Alaska Native women: US, 1999-2004. | Q50123145 | ||
Concordance of cancer registry and self-reported race, ethnicity, and cancer type: a report from the American Cancer Society's studies of cancer survivors | Q58613786 | ||
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer | Q60683126 | ||
Breast cancer mortality among American Indian and Alaska Native women, 1990-2009 | Q64125864 | ||
Scientists rise up against statistical significance | Q66778032 | ||
Disparities in breast cancer treatment among American Indian, Hispanic and non-Hispanic White Women Enrolled in Medicare | Q80736709 | ||
Indian Health Service Care System and Cancer Stage in American Indians and Alaska Natives | Q87955235 | ||
Cancer survival among Alaska Native people | Q88175757 | ||
Racial disparities in postmastectomy breast reconstruction: National trends in utilization from 2005 to 2014 | Q88373583 | ||
Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia | Q90471688 | ||
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx | Q92439861 | ||
P577 | publication date | 2020-09-14 | |
P1433 | published in | Cancer | Q326041 |
P1476 | title | Genomic expression assay testing among American Indian and Alaska Native women with breast cancer |
Search more.